Compare KOPN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | TOI |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.9M | 444.1M |
| IPO Year | 1992 | N/A |
| Metric | KOPN | TOI |
|---|---|---|
| Price | $2.31 | $3.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.25 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 2.8M | 2.3M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $45,602,295.00 | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | $43.33 | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.02 | ★ 21.67 |
| 52 Week Low | $0.71 | $0.17 |
| 52 Week High | $4.16 | $4.88 |
| Indicator | KOPN | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 48.89 |
| Support Level | $2.40 | $3.64 |
| Resistance Level | $2.44 | $3.90 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 11.48 | 51.13 |
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.